Early pulmonary arterial hypertension immediately after closure of a ventricular or complete atrioventricular septal defect beyond 6 months of age

被引:3
|
作者
Heck, P. Bambul [1 ]
Eicken, A. [1 ]
Kasnar-Samprec, J. [2 ]
Ewert, P. [1 ]
Hager, A. [1 ]
机构
[1] Tech Univ Munich, Dept Paediat Cardiol & Congenital Heart Dis, DHM, Lazarett Str 36, D-80290 Munich, Germany
[2] Tech Univ Munich, Dept Cardiovasc Surg, DHM, D-80290 Munich, Germany
关键词
Pulmonary arterial hypertension; VSD; CONGENITAL HEART-DISEASE; EISENMENGER-SYNDROME; SURGICAL CLOSURE; FOLLOW-UP; NITRIC-OXIDE; REPAIR; THERAPY; ADULTS;
D O I
10.1016/j.ijcard.2016.11.056
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Pulmonary arterial hypertension (PAH) is virtually absent after closure of ventricular septal defect (VSD) in the first six months of life. However the prevalence of PAH in patients, who underwent VSD closure later, is not clear. The aim of this study was to analyse the prevalence of PAH after a successful VSD closure after the age of 6 months and whether there are risk factors for developing PAH. Methods: Echocardiographic and right heart catheter data of patients with VSD or complete atrioventricular septal defect, who underwent VSD closure after the age of 6 months in our institution between 01/2005 and 06/2014, were retrospectively analyzed. PAH was defined as mean pulmonary arterial pressure (mPAP) of >= 25 mm Hg or tricuspid regurgitation jet velocity of >= 3.5 m/s. Results: In 228 patients (median age at shunt closure 4.0 years, range 0.5-69) and 174 complete follow-up data (median follow-up 3.7 years, range 0.5-39.4), 9 patients needed pulmonary vasodilator therapy after shunt closure, 4 of them temporarily for up to 79 months. Three patients are still on vasodilator treatment 1, 2.6 and 6 years after surgery, other two were lost to follow-up. Another 6 patients with preoperatively borderline hemo-dynamics due to elevated mPAP and pulmonary vascular resistance, recovered well without signs of postoperative PAH. Conclusion: With the current practice for safe late VSD closure, PAH is very rare at least in the first years of follow-up. In most patients with perioperative PAH, this condition appears to be transient and shows good response on pulmonary vasodilator treatment. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:313 / 318
页数:6
相关论文
共 50 条
  • [1] Closure of Ventricular Septal Defect with Severe Pulmonary Hypertension
    Samankatiwat, P.
    17TH ANNUAL MEETING OF THE ASIAN SOCIETY FOR CARDIOVASCULAR AND THORACIC SURGERY - ASCVTS, 2009, : 89 - 91
  • [2] Targeted Therapy Is Required for Management of Pulmonary Arterial Hypertension After Defect Closure in Adult Patients With Atrial Septal Defect and Associated Pulmonary Arterial Hypertension
    Fujino, Takeo
    Yao, Atsushi
    Hatano, Masaru
    Inaba, Toshiro
    Muraoka, Hironori
    Minatsuki, Shun
    Imamura, Teruhiko
    Maki, Hisataka
    Kinugawa, Koichiro
    Ono, Minoru
    Nagai, Ryozo
    Komuro, Issei
    INTERNATIONAL HEART JOURNAL, 2015, 56 (01) : 86 - 93
  • [3] Impact of Age and of the Patent Ductus Arteriosus on Pulmonary Hemodynamics in Children with Complete Atrioventricular Septal Defect
    Rocha, Lucas Oliveira
    Miyague, Nelson Itiro
    Solarewicz, Leo Agostinho
    Fernandes-Silva, Miguel Morita
    PEDIATRIC CARDIOLOGY, 2024,
  • [4] The prevalence of pulmonary arterial hypertension before and after atrial septal defect closure at adult age: A systematic review
    Zwijnenburg, Roxanne D.
    Baggen, Vivan J. M.
    Geenen, Laurie W.
    Voigt, Kelly R.
    Roos-Hesselink, Jolien W.
    van den Bosch, Annemien E.
    AMERICAN HEART JOURNAL, 2018, 201 : 63 - 71
  • [5] Progressive Pulmonary Hypertension Post Atrial Septal Defect Device Closure-Early Symptomatic Improvement may not Predict Outcome
    O'Donnell, C.
    Ruygrok, P. N.
    Whyte, K.
    Wilson, N. J.
    HEART LUNG AND CIRCULATION, 2010, 19 (12) : 713 - 716
  • [6] Percutaneous atrial septal defect closure in patients with pulmonary arterial hypertension
    Valdeolmillos, Estibaliz
    Foray, Claire
    Albenque, Gregoire
    Batteux, Clement
    Petit, Jerome
    Lecerf, Florence
    Jais, Xavier
    Sitbon, Olivier
    Montani, David
    Savale, Laurent
    Humbert, Marc
    Hascoet, Sebastien
    EUROPEAN RESPIRATORY JOURNAL, 2024, 63 (05)
  • [7] Comparative analysis of early and middle outcomes of the arterial switch operation in children with complete transposition of the great arteries with ventricular septal defect and severe pulmonary artery hypertension
    Liu Cheng-hu
    Su Jun-wu
    Li Zhi-qiang
    Fan Xiang-ming
    Chen Yan
    He Yan
    Liu Ying-long
    CHINESE MEDICAL JOURNAL, 2013, 126 (11) : 2074 - 2078
  • [8] Outcomes in Patients with Pulmonary Arterial Hypertension Underwent Transcatheter Closure of an Atrial Septal Defect
    Seol, Jae-Hee
    Jung, Se-Yong
    Lee, Han-Byul
    Kim, Ah-Young
    Kim, Eun-Hwa
    Min, In-Kyung
    Kim, Nam-Kyun
    Choi, Jae-Young
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (07)
  • [9] Pulmonary stenosis development and reduction of pulmonary arterial hypertension in atrioventricular septal defect: a case report
    Emeline Barth
    Hélène Bouvaist
    Stéphanie Marlière
    Gérard Ninet
    Gérald Vanzetto
    Journal of Cardiothoracic Surgery, 4
  • [10] Pulmonary stenosis development and reduction of pulmonary arterial hypertension in atrioventricular septal defect: a case report
    Barth, Emeline
    Bouvaist, Helene
    Marliere, Stephanie
    Ninet, Gerard
    Vanzetto, Gerald
    JOURNAL OF CARDIOTHORACIC SURGERY, 2009, 4 : 49